stockrowPerrigo Company plc
PRGO Healthcare Drug Manufacturers Specialty & Generic
Perrigo Company plc’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, down 2.75% from fiscal 2024.
- Revenue
- −5.24%
- EPS
- −494.6%
- Free cash flow
- +138.5%
- Total debt
- −9.62%
Quarter to September 2026, against a year earlier
Follow PRGO
Alert me
Perrigo Company plc (PRGO) Free cash flow
Perrigo Company plc's free cash flow for fiscal 2025 was $150.7M, down 47.6% from $287.7M in fiscal 2024. Over the twelve months to 30 September 2026 it was $168.2M. Over the past ten years it has ranged from $8.0M (fiscal 2021) to $1.1B (fiscal 2015); the current reading is higher than 17% of that period. Perrigo Company plc ranks 20th of 84 Drug Manufacturers Specialty & Generic companies by free cash flow.
Free cash flow, annual
Embed this chart
Annual newest first
| Period | Free cash flow | Change |
|---|---|---|
| FY2025 | $150.7M | (47.62%) |
| FY2024 | $287.7M | (12.29%) |
| FY2023 | $328.0M | 36.84% |
| FY2022 | $239.7M | 2,896.25% |
| FY2021 | $8.0M | (98.30%) |
| FY2020 | $469.9M | 85.73% |
| FY2019 | $253.0M | (49.81%) |
| FY2018 | $504.1M | (27.74%) |
| FY2017 | $697.6M | (22.70%) |
| FY2016 | $902.4M | 211.82% |
Quarterly newest first
| Period | Free cash flow | Change |
|---|---|---|
| Sep 2026 | $78.7M | 15.23% |
| Jun 2026 | $68.3M | — |
| Mar 2026 | −$126.0M | — |
| Dec 2025 | $151.0M | 357.58% |
| 43 more quarters | Free account |
Against its own ten years
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| BCRX BioCryst Pharmaceuticals, Inc. compare | $366.4M |
| TRLV Trulieve Cannabis Corp. compare | $242.5M |
| PBH Prestige Consumer Healthcare Inc. compare | $214.2M |
| ANIP ANI Pharmaceuticals, Inc. compare | $205.3M |
| PRGO Perrigo Company plc | $168.2M |
| XERS Xeris Biopharma Holdings, Inc. compare | $73.6M |
| RGC Regencell Bioscience Holdings Limited compare | −$14.7M |
| HCM HUTCHMED (China) Limited Sponsored ADR compare | −$171.8M |
| ALVO Alvotech compare | −$211.7M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)
More on PRGO
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement